Levaquin Label Update

The FDA updated the Levaquin label last week.

 June 28, 2019, the FDA updated the Levaquin label MEDICATION GUIDE which is the information given to patients.

The FDA added more psychiatric adverse event warnings to the MEDICATION GUIDE including:

  • Feeling agitated
  • Reduced awareness of surroundings
  • Memory problems
  • False or strange thoughts or beliefs (delusions)

The June 28, 2019 MEDICATION GUIDE also now states that “Tendon problems may be permanent.”

Share

3 thoughts on “Levaquin Label Update”

  1. Hi How can I get a copy of this update? I have searched the FDA site but cannot find it. We live in the UK and my wife was floxed in Spain 9 years ago. Most doctors here don’t recognise the warnings and we battle on. Your site is a tremendous help and support

    Reply
  2. My chiropractor recently told me he was once prescribed Levaquin and all he could think of was driving his car off a bridge. This was quite awhile ago. He immediately called his doc who told him to stop taking it immediately. Wish other docs would have been as smart.

    Reply

Leave a Comment

Comments Protected by WP-SpamShield Anti-Spam